Our News on Newswise

Newswise: 664fd3f2e5362_OlazagastiCoralv05-2024.jpg

Internationally Trained Female Oncologists Face Many Discrimination Challenges in the U.S.

ASCO: A new study highlights workplace discrimination reported by internationally trained female oncologists. Dr. Coral Olazagasti will present study findings that showed female oncologists reported much higher levels of gender or...
23-May-2024 7:05 PM EDT Add to Favorites

Newswise: 664fdd4a7ee84_LandgrenC.Ola05-2024.jpg

Quadruple Therapies and the Future of Multiple Myeloma Treatment

ASCO: Treatment options for multiple myeloma are shifting rapidly, with new patients increasingly being treated with a 4-part drug combination that includes a new immunotherapy agent. What does this mean for patients, and how will treatment change...
23-May-2024 7:05 PM EDT Add to Favorites

Sylvester Research Shows New Treatment May Enable More Patients With High-Risk Blood Cancers to Receive Stem Cell Transplants

AT ASCO: A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors.
23-May-2024 6:05 PM EDT Add to Favorites

Newswise: 664d59fd113a9_LandgrenOlaHeadshotRetouchesHi-ResHoriz.jpg

Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval

An FDA committee voted unanimously last month to approve a new clinical endpoint, minimal residual disease, when evaluating proposed drugs to treat multiple myeloma. The 12-0 vote was based primarily on an analysis spearheaded by C. Ola Landgren,...
21-May-2024 10:05 PM EDT Add to Favorites

Newswise: 663e97f289fff_WattsJustinHiRes231114ASHPortraits-215.jpg

Study: Older Adults With Aggressive Blood Cancer Are Responsive to Treatment and Show Prolonged Survival

Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.
10-May-2024 5:05 PM EDT Add to Favorites

Newswise: 663c2f8458d0f_SBTI-240415SCCCBrain-116-X2.jpg

Sylvester Cancer Launches New Brain Tumor Institute to Personalize Brain Cancer Treatment

Sylvester Comprehensive Cancer Center today announced establishment of the Sylvester Brain Tumor Institute. It will focus on personalized medicine approaches for treating all patients with brain tumors.
8-May-2024 9:05 PM EDT Add to Favorites

Newswise: 663c18c71c97d_ShultzJames2023.jpg

Caribbean Teams Innovate to Protect Cancer Patients from Compounding Disasters

A new Lancet Oncology article describes how climate-driven risks in the Caribbean negatively affect every step in the cancer control continuum, from etiology to survivorship.
8-May-2024 8:05 PM EDT Add to Favorites

Newswise: 66342f924d49d_DHAR20180518uhealth329-Edit.jpg

Sylvester Researchers Develop a Nanoparticle That Can Penetrate the Blood-Brain Barrier

Researchers at Sylvester Comprehensive Cancer Center have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to kill primary breast cancer tumors and brain metastases in one treatment.
2-May-2024 8:05 PM EDT Add to Favorites


See All News

Our YouTube Videos

About

About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.

Experts

Contacts

Laura Castro
Director, Marketing and Communications

laura.castro@med.miami.edu

305-243-8294

Melissa Gomez
Assistant Vice President, Marketing & Communications

melissa.gomez@med.miami.edu

786-835-4356

Kai Hill
Director, Media Relations & Medical Communications

khill@med.miami.edu

305-332-3189

Joanna Palmer
Executive Director of Media Relations & Medical Communications

Joanna.palmer@med.miami.edu

786-270-9909

Gary Polakovic
Director of Medical Communications and Media Relations for Sylvester Comprehensive Cancer Center.

gary.polakovic@med.miami.edu

305-213-4642

Sandy Van

Sandy.Van@miami.edu

Twitter

Instagram

close
0.93274